Support Line: 0800 002 9002
General Enquiries: 01223 870008
  »  Pazopanib, Sunitinib, Nivolumab: A Patient Consultant Experience

Pazopanib, Sunitinib, Nivolumab: A Patient Consultant Experience

by | Jun 29, 2016

.

Pazopanib, Sunitinib, Nivolumab: A Patient Consultant Experience – An Insight In To Drugs and Their Side Effects

Dr Fran King has kidney cancer and has been prescribed the drugs Pazopanib, Sunitinib and is currently on a clinical trial through Bristol-Myers Squibb for Nivolumab. Here, along with his oncologist, Dr Kate Fife of Addenbrooke’s Hospital, Cambridge, Frank talks about those drugs effects and his kidney cancer journey.

<a href="https://www.kcuk.org.uk/author/mp/" target="_self">Malcolm Packer</a>

Malcolm Packer

Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.